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The mechanism of GnRHa inhibitory action on the gonadal axis is thought to be the down-regulation of LH secretion from the pituitary, but the loss of LH bioactivity also seems to be one of the main mechanisms of GnRHa inhibitory action (Meldrum et al., 1984) .
In this study the changes in the mRNA 
Materials and Methods
Animals and sample collection Immature female Sprague-Dawley rats (21 days old) were treated s.c. with a sustainedrelease formulation of GnRHa (TAP-144-SR, Takeda Chemical Ind., Ltd.) at a dose of 0.94 mg/rat and were sacrified by decapitation 1, 2, 3, 4, 5, or 18 hours or 3, 7, 14 or 28 days after GnRHa injection. The pituitaries were harvested under sterile conditions, and were immediately quick-frozen in liquid nitrogen and stored at blood was collected, and the serum was stored at -20•Ž until assayed. TAP-144-SR is a depot formulation of a GnRHa (D-Leu6/Pro9-ethylamide) using copolymers composed of lactic acid/glycolic acid which allows release of the GnRHa over 4 weeks. (Ogawa et al., 1989) . In the previous study this sustained GnRHa of 0.94mg/28 days delayed vaginal opening in immature female rats (Yanagisawa et al., 1988) . Therefore, we used the same dosage of GnRHa on immature female rats as in the previous study.
To monitor the pituitary response to GnRH, blood samples were obtained by heart puncture under light ether anesthesia before and 30 minutes after sc injection of 1 mg of native GnRH (Lutamin, Daiichi Pharmaceutical Co., Ltd.) on day 0, 7, 14, 21 and 28.
For RNA extraction from pituitaries obtained from day 0 to day 3, 2-3 pituitaries were combined to get a sufficient amount of RNA. Serum LH Serum LH concentrations were increased at hour 1 (p<0.05) and continued to rise until hour 2 (p <0.01).
Thereafter, the levels decreased gradually but were higher than those measured in the intact control animals on day 3 (p<0.01).
On day 28 the concentrations had returned to the control levels (Fig. 2, 3 
